Bonesupport Holding AB (BONEX) - Total Liabilities
Based on the latest financial reports, Bonesupport Holding AB (BONEX) has total liabilities worth Skr169.24 Million SEK (≈ $18.21 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Bonesupport Holding AB to track the company's year-over-year net asset growth rate.
Bonesupport Holding AB - Total Liabilities Trend (2014–2024)
This chart illustrates how Bonesupport Holding AB's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Bonesupport Holding AB to measure how efficiently the company converts operating cash flow to free cash.
Bonesupport Holding AB Competitors by Total Liabilities
The table below lists competitors of Bonesupport Holding AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Innovative Industrial Properties Inc
NYSE:IIPR
|
USA | $474.57 Million |
|
Exail Technologies S.A.
PA:EXA
|
France | €700.40 Million |
|
Redfin Corp
NASDAQ:RDFN
|
USA | $1.23 Billion |
|
UroGen Pharma Ltd
NASDAQ:URGN
|
USA | $377.94 Million |
|
Magellan Aerospace Corporation
TO:MAL
|
Canada | CA$391.03 Million |
|
AFFIN Holdings Bhd
KLSE:5185
|
Malaysia | RM111.87 Billion |
|
Reysas Gayrimenkul Yatirim Ortakligi AS
IS:RYGYO
|
Turkey | TL10.90 Billion |
|
ADIENT PLC DL-001
F:18I
|
Germany | €6.68 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Bonesupport Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bonesupport Holding AB market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.34 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bonesupport Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bonesupport Holding AB (2014–2024)
The table below shows the annual total liabilities of Bonesupport Holding AB from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr152.23 Million ≈ $16.38 Million |
+5.98% |
| 2023-12-31 | Skr143.64 Million ≈ $15.46 Million |
+39.60% |
| 2022-12-31 | Skr102.89 Million ≈ $11.07 Million |
+31.55% |
| 2021-12-31 | Skr78.22 Million ≈ $8.42 Million |
+17.94% |
| 2020-12-31 | Skr66.32 Million ≈ $7.14 Million |
-7.92% |
| 2019-12-31 | Skr72.02 Million ≈ $7.75 Million |
+51.28% |
| 2018-12-31 | Skr47.61 Million ≈ $5.12 Million |
-67.37% |
| 2017-12-31 | Skr145.90 Million ≈ $15.70 Million |
-5.57% |
| 2016-12-31 | Skr154.50 Million ≈ $16.63 Million |
+69.22% |
| 2015-12-31 | Skr91.31 Million ≈ $9.83 Million |
+2.43% |
| 2014-12-31 | Skr89.14 Million ≈ $9.59 Million |
-- |
About Bonesupport Holding AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more